Catalyst Wire Dossier Catalyst Wire Dossier

Inactivated Varicella Zoster Virus Vaccine

Varicella Zoster Virus vaccine (inactivated) · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Inactivated Varicella Zoster Virus Vaccine, covering 2015-08-13 to 2019-03-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013) [Phase 1]

See pricing